Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
OwnerKendall King, Rebecca Madura +1inventors
InventorsKendall King, Rebecca Madura, Everett Rosey
Life of this patent
Estimating the term…
Abstract
The present invention relates to mhp3 nucleic acids and proteins encoded by the foregoing. The present invention further relates to novel apoprotein antigens encoded by mhp3 for use in vaccines to prevent and treat diseases caused by infection with Mycoplasma hyopneumoniae. The invention further relates to methods for the recombinant production of such antigens.
Claims34
-11. (canceled)
An immunogenic protein having an amino acid sequence as depicted in SEQ ID NO:4, or a fragment, variant or derivative thereof, wherein the immunogenic protein does not have a fatty acid acylated cysteine followed by the amino acid sequence Trp Asp Lys Glu, and does not have a C-terminal homoserine lactone.
A method of treating or preventing a disease or disorder in an animal caused by infection with Mycoplasma hyopneumoniae comprising administering to the animal a vaccine formulation comprising (i) a protein having an amino acid sequence comprising at least 30 contiguous amino acids of SEQ ID NO:4, wherein said protein does not have a fatty acid acylated cysteine followed by the amino acid sequence Trp Asp Lys Glu, and (ii) a pharmaceutically acceptable carrier, in an amount sufficient to elicit an increase in Mycoplasma hyopneumoniae specific cellular or humoral responses.
A method of treating or preventing a disease or disorder in an animal caused by infection with Mycoplasma hyopneumoniae comprising administering to the animal a vaccine formulation comprising (i) an antigenic or immunogenic protein having an amino acid sequence comprising at least amino acids 1-30 of SEQ ID NO:4, and (ii) a pharmaceutically acceptable carrier, in an amount sufficient to elicit an increase in Mycoplasma hyopneumoniae specific cellular or humoral responses.
An isolated or purified DNA encoding in the mycoplasmal genetic code a protein having an amino acid sequence comprising at least 30 contiguous amino acids of SEQ ID NO:2, or its complement.
A DNA encoding in the universal genetic code a protein having an amino acid sequence comprising at least 30 contiguous amino acids of SEQ ID NO:4, or its complement.
An isolated DNA comprising a fragment of 15-40 nucleotides, which fragment hybridizes under stringent conditions for PCR to a DNA encoding in the mycoplasmal genetic code a protein having a sequence of at least 5 contiguous amino acids of SEQ ID NO:2, or its complement.
An isolated DNA comprising a fragment of at least 90 nucleotides, which fragment hybridizes under conditions of high stringency for filter hybridization to a DNA encoding in the mycoplasmal genetic code a protein having a sequence of at least 30 contiguous amino acids of SEQ ID NO:2, or its complement.
A kit comprising in at least one container a first isolated DNA comprising a fragment of at least 15 nucleotides, which fragment hybridizes under stringent conditions for PCR to a DNA encoding in the mycoplasmal genetic code a protein having a sequence of at least 5 contiguous amino acids of SEQ ID NO:2, and a second isolated DNA comprising a fragment of at least 15 nucleotides, which fragment hybridizes under stringent conditions for PCR to a DNA complementary to a DNA encoding in the mycoplasmal genetic code a protein having a sequence of at least 5 contiguous amino acids of SEQ ID NO:2, wherein said kit comprises a statement indicating that the kit is useful for diagnosis of M. hyopneumoniae infection.
A kit comprising in at least one container a protein having an amino acid sequence comprising at least 30 contiguous amino acids of SEQ ID NO:4 and a statement indicating that the kit is useful for diagnosis of M. hyopneumoniae infection.
Dependencies are inferred from the claim text.